Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking
Tracking tumour evolution in a patient via circulating tumour DNA (ctDNA) is complicated due to the unknown mix of fragmented alleles from different cancer lesions. Here, the authors make use of a rapid autopsy program to demonstrate how representative ctDNA profiling is of metastasis, as well as pr...
Guardado en:
Autores principales: | George D. Cresswell, Daniel Nichol, Inmaculada Spiteri, Haider Tari, Luis Zapata, Timon Heide, Carlo C. Maley, Luca Magnani, Gaia Schiavon, Alan Ashworth, Peter Barry, Andrea Sottoriva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/98ada904713047afa84798009c85187b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
por: Ahmet Acar, et al.
Publicado: (2020) -
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
por: Sisi Chen, et al.
Publicado: (2019) -
Identification of germline cancer predisposition variants during clinical ctDNA testing
por: Leigh Anne Stout, et al.
Publicado: (2021) -
Rational design of on-chip gold plasmonic nanoparticles towards ctDNA screening
por: Amogha Tadimety, et al.
Publicado: (2021) -
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Bin Qiu, et al.
Publicado: (2021)